NYSE:MED Medifast (MED) Stock Price, News & Analysis $18.70 -0.29 (-1.53%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Medifast alerts: Email Address About Medifast Stock (NYSE:MED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medifast alerts:Sign Up Key Stats Today's Range$18.43▼$18.7750-Day Range$17.91▼$21.9652-Week Range$17.73▼$82.51Volume534,923 shsAverage Volume430,619 shsMarket Capitalization$204.58 millionP/E Ratio3.01Dividend YieldN/APrice Target$49.75Consensus RatingReduce Company OverviewMedifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More… AI expert reveals new Nvidia prediction (Ad)Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released my latest prediction and believe it or not, I’m advising NOT pour all your money into Nvidia right nowClick here to see why Medifast Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 68th PercentileMedifast scored higher than 68% of companies evaluated by MarketBeat, and ranked 69th out of 150 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingReduce Consensus RatingMedifast has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days.Read more about Medifast's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-31.39% Earnings GrowthEarnings for Medifast are expected to decrease by -31.39% in the coming year, from $1.37 to $0.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 3.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 3.01, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.82.Price to Book Value per Share RatioMedifast has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medifast's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted19.51% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Medifast has recently decreased by 4.61%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast does not have a long track record of dividend growth. Sustainability and ESG2.0 / 5Environmental Score-4.00 Percentage of Shares Shorted19.51% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Medifast has recently decreased by 4.61%, indicating that investor sentiment is improving. News and Social Media1.3 / 5News Sentiment0.37 News SentimentMedifast has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Medifast this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Stock News HeadlinesMedifast (MED): A Bull Case TheorySeptember 11, 2024 | msn.comPersonal Care Stocks Q2 Results: Benchmarking Medifast (NYSE:MED)September 11, 2024 | finance.yahoo.comOur #1 Ticker for the Rare "Retirement Window"We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.September 20, 2024 | Behind the Markets (Ad)The Schall Law Firm Is Looking Into Medifast Inc For Possible Securities Law Violations And Investors With Losses Should Reach OutSeptember 11, 2024 | stockhouse.comIs Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?September 8, 2024 | finance.yahoo.comSpotting Winners: Edgewell Personal Care (NYSE:EPC) And Personal Care Stocks In Q2September 4, 2024 | theglobeandmail.comMedifast: Reorganization, GLP-1 Medication, And FCF Imply UndervaluationSeptember 4, 2024 | seekingalpha.comMedifast Business Continues To Shrink, Stock Still RiskyAugust 27, 2024 | seekingalpha.comSee More Headlines MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? Medifast's stock was trading at $67.22 at the start of the year. Since then, MED stock has decreased by 72.2% and is now trading at $18.70. View the best growth stocks for 2024 here. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) announced its earnings results on Monday, August, 5th. The specialty retailer reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.56. The specialty retailer had revenue of $168.56 million for the quarter, compared to analyst estimates of $160.44 million. Medifast had a net margin of 3.81% and a trailing twelve-month return on equity of 25.77%. Who are Medifast's major shareholders? Top institutional shareholders of Medifast include Renaissance Technologies LLC (8.76%), Millennium Management LLC (4.29%), AQR Capital Management LLC (3.57%) and Acadian Asset Management LLC (3.09%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ) and Intel (INTC). Company Calendar Last Earnings8/05/2024Today9/20/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$49.75 High Stock Price Target$82.00 Low Stock Price Target$17.50 Potential Upside/Downside+166.5%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$6.20 Trailing P/E Ratio3.01 Forward P/E Ratio13.63 P/E GrowthN/ANet Income$99.42 million Net Margins3.81% Pretax Margin4.84% Return on Equity25.77% Return on Assets17.04% Debt Debt-to-Equity RatioN/A Current Ratio2.98 Quick Ratio2.46 Sales & Book Value Annual Sales$1.07 billion Price / Sales0.19 Cash Flow$10.85 per share Price / Cash Flow1.72 Book Value$18.50 per share Price / Book1.01Miscellaneous Outstanding Shares10,940,000Free Float10,664,000Market Cap$204.25 million OptionableOptionable Beta1.13 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NYSE:MED) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.